ARTICLE | Company News
Management tracks
March 6, 2015 2:27 AM UTC
Gary Burgess resigned as SVP of clinical research and CMO of Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), effective April 2. The company did not name a successor.
Aura Biosciences Inc. (Cambridge, Mass.) hired Alison Lawton as COO, a newly created position. Lawton was COO at OvaScience Inc. (NASDAQ:OVAS). ...